LEMAITRE VASCULAR, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
LEMAITRE VASCULAR, INC. (LMAT) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$308.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-05
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$308.00K, a 114.29% decline year-over-year.
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$1.45M, a 240.25% decline year-over-year.
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $501.00K.
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $86.00K, a 95.56% decline year-over-year.
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $3.77M.
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$1.56M, a 210.88% decline from fiscal 2023.
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $1.41M.
- LEMAITRE VASCULAR, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was -$2.60M.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$308.00K 10-Q · filed 2026-08-05 | -$1.75M 10-Q · filed 2026-08-05 | -$1.25M derived: sum of 3 quarters · filed 2026-08-05 | -$1.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$1.45M 10-Q · filed 2026-08-05 | -$945.00K derived: sum of 2 quarters · filed 2026-08-05 | -$859.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $587.00K derived: sum of 2 quarters · filed 2026-02-26 | $2.74M derived: sum of 3 quarters · filed 2026-08-05 | $3.77M 10-K · filed 2026-02-26 |
| 2025-09-30 | $86.00K 10-Q · filed 2025-11-07 | $2.24M derived: sum of 2 quarters · filed 2026-08-05 | $3.27M 10-Q · filed 2025-11-07 | $244.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $2.15M 10-Q · filed 2026-08-05 | $3.19M 10-Q · filed 2026-08-05 | $158.00K derived: sum of 3 quarters · filed 2026-08-05 | $2.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $1.03M 10-Q · filed 2026-08-05 | -$2.00M derived: sum of 2 quarters · filed 2026-08-05 | -$59.00K derived: sum of 3 quarters · filed 2026-08-05 | $405.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2024-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.09M derived: sum of 2 quarters · filed 2026-02-26 | -$626.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.56M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.94M 10-Q · filed 2025-11-07 | $2.40M derived: sum of 2 quarters · filed 2025-11-07 | $1.47M 10-Q · filed 2025-11-07 | $3.55M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $464.00K 10-Q · filed 2025-11-07 | -$469.00K 10-Q · filed 2025-08-06 | $1.61M derived: sum of 3 quarters · filed 2026-02-26 | $728.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$933.00K 10-Q · filed 2025-11-07 | $1.15M derived: sum of 2 quarters · filed 2026-02-26 | $264.00K derived: sum of 3 quarters · filed 2026-02-26 | $14.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.20M derived: sum of 2 quarters · filed 2026-02-26 | $947.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.41M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$883.00K 10-Q · filed 2024-11-08 | -$1.13M derived: sum of 2 quarters · filed 2024-11-08 | -$674.00K 10-Q · filed 2024-11-08 | $1.42M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$250.00K 10-Q · filed 2024-11-08 | $209.00K 10-Q · filed 2024-08-08 | $2.31M derived: sum of 3 quarters · filed 2025-02-28 | $622.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $459.00K 10-Q · filed 2024-11-08 | $2.56M derived: sum of 2 quarters · filed 2025-02-28 | $872.00K derived: sum of 3 quarters · filed 2025-02-28 | -$948.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $413.00K derived: sum of 2 quarters · filed 2025-02-28 | -$1.41M derived: sum of 3 quarters · filed 2025-02-28 | -$2.60M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$1.68M 10-Q · filed 2023-11-07 | -$3.50M derived: sum of 2 quarters · filed 2023-11-07 | -$4.69M 10-Q · filed 2023-11-07 | -$5.49M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$1.82M 10-Q · filed 2023-11-07 | -$3.01M 10-Q · filed 2023-08-08 | -$3.81M derived: sum of 3 quarters · filed 2024-02-29 | -$4.20M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$1.19M 10-Q · filed 2023-11-07 | -$1.99M derived: sum of 2 quarters · filed 2024-02-29 | -$2.38M derived: sum of 3 quarters · filed 2024-02-29 | -$2.16M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$799.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.19M derived: sum of 2 quarters · filed 2024-02-29 | -$972.00K derived: sum of 3 quarters · filed 2024-02-29 | -$1.91M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$393.00K 10-Q · filed 2022-11-08 | -$173.00K derived: sum of 2 quarters · filed 2022-11-08 | -$1.11M 10-Q · filed 2022-11-08 | $373.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $220.00K 10-Q · filed 2022-11-08 | -$718.00K 10-Q · filed 2022-08-05 | $766.00K derived: sum of 3 quarters · filed 2023-03-01 | $1.92M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$938.00K 10-Q · filed 2022-11-08 | $546.00K derived: sum of 2 quarters · filed 2023-03-01 | $1.70M derived: sum of 3 quarters · filed 2023-03-01 | $3.06M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.63M derived: sum of 2 quarters · filed 2023-03-01 | $4.00M derived: sum of 3 quarters · filed 2023-03-01 | $2.48M 10-K · filed 2023-03-01 |
| 2020-09-30 | $1.15M 10-Q · filed 2021-11-04 | $2.52M derived: sum of 2 quarters · filed 2021-11-04 | $998.00K 10-Q · filed 2021-11-04 | $1.89M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $1.37M 10-Q · filed 2021-11-04 | -$152.00K 10-Q · filed 2021-08-05 | $735.00K derived: sum of 3 quarters · filed 2022-02-28 | -$341.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$1.52M 10-Q · filed 2021-11-04 | -$631.00K derived: sum of 2 quarters · filed 2022-02-28 | -$1.71M derived: sum of 3 quarters · filed 2022-02-28 | -$1.43M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $887.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$189.00K derived: sum of 2 quarters · filed 2022-02-28 | $85.00K derived: sum of 3 quarters · filed 2022-02-28 | -$107.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | -$1.08M 10-Q · filed 2020-11-06 | -$802.00K derived: sum of 2 quarters · filed 2020-11-06 | -$994.00K 10-Q · filed 2020-11-06 | -$1.41M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $274.00K 10-Q · filed 2020-11-06 | $82.00K 10-Q · filed 2020-08-06 | -$336.00K derived: sum of 3 quarters · filed 2021-03-12 | -$611.00K derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | -$192.00K 10-Q · filed 2020-11-06 | -$610.00K derived: sum of 2 quarters · filed 2021-03-12 | -$885.00K derived: sum of 3 quarters · filed 2021-03-12 | -$2.09M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | -$418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$693.00K derived: sum of 2 quarters · filed 2021-03-12 | -$1.89M derived: sum of 3 quarters · filed 2021-03-12 | -$1.61M 10-K · filed 2021-03-12 |
| 2018-09-30 | -$275.00K 10-Q · filed 2019-11-08 | -$1.48M derived: sum of 2 quarters · filed 2019-11-08 | -$1.19M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$1.20M 10-Q · filed 2019-11-08 | -$918.00K 10-Q · filed 2019-08-06 | ||
| 2018-03-31 | $283.00K 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $2.29M 10-K · filed 2020-03-12 | |||
| 2016-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$1.06M derived: sum of 2 quarters · filed 2019-03-11 | -$1.46M derived: sum of 3 quarters · filed 2019-03-11 | -$534.00K 10-K · filed 2019-03-11 |
| 2016-09-30 | $312.00K 10-Q · filed 2016-11-04 | -$93.00K derived: sum of 2 quarters · filed 2016-11-04 | $836.00K 10-Q · filed 2016-11-04 | |
| 2016-06-30 | -$405.00K 10-Q · filed 2016-08-05 | $524.00K 10-Q · filed 2016-08-05 | ||
| 2016-03-31 | $929.00K 10-Q · filed 2016-05-06 | |||
| 2015-09-30 | -$508.00K 10-Q · filed 2016-11-04 | -$72.00K derived: sum of 2 quarters · filed 2016-11-04 | -$1.67M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | $436.00K 10-Q · filed 2016-08-05 | -$1.16M 10-Q · filed 2016-08-05 | ||
| 2015-03-31 | -$1.60M 10-Q · filed 2016-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |